Loading...
DOCUMENTS
20
NOTICES
33
MOTS CLES
Endoscopic treatment
Patients experience
Inflammatory Bowel Diseases
Rituximab plus chlorambucil
IL23
Surgery
Survival
Acceptability
Clinical trial
Ustekinumab
Cancer
Kidney diseases
Stricture
Upper gastrointestinal tract
DNA methylation
MICROBIOTA
Inclusion
Colonic epithelial primary cells
Parvimonas micra
Méthylation
Alkylating agents
18 FDG-PET/CT
Screening
Rituximab
Cost effectiveness
Anti-TNF
Original Article Clinical
MALT
T1118 translocation
DNA METHYLATION
Bacteria
Bactéries
Gene expression
Biologics
Tuberculosis
Microbiote
Gènes
Eradication
Genes
Over 80s
Inhibitor
Primary sclerosing cholangitis
Clinical guidelines
Biomarker
Methylation
Drug
Maintenance therapy
Epigénétiques
Gene methylation
Tailored therapy
Algorithm
Immunosuppressant
Microbiota
IL12
Crohn’s disease
Anti-TNF agents
Résistance
Eligibility
IBD
Therapeutics
MARKER
Heart disease risk factors
Dysbiose
Venous thromboembolism
Inflammatory bowel disease
Neoadjuvant chemotherapy
CARCINOGENESIS
Helicobacter pylori
Vedolizumab
Patient-reported outcome
Ulcerative colitis
Colorectal cancer
Contraindication
Disease Progression
Thérapie ciblée
Monitoring
Inflammatory bowel diseases
Epigenetics
Small molecules
Cell adhesion
Resistance
Disability
Colon cancer
Immune cells
Colorectal cancer Colibactin and lipids
Disease progression
Dysbiosis
Colon
Consensus
RISK
Fecal microbiota
Safety
Effectiveness
Colectomy
PCR
Intestinal crypts
MORTALITY
Crohn's disease
COLON-CANCER
HIV
Early detection of Colon Cancer using Molecular Markers and Microbiota , EA 7375 | |
---|---|
Institutions |
UPEC |
Adresse |
Université Paris-Est Créteil Groupe Hospitalier Henri Mondor Service de Gastroentérologie 51 Av Maréchal de Lattre de Tassigny 94010 Créteil cedex |
Courriel |
|
Site Internet |
|
Rattachement(s) |
|
Direction |
Aurélien AMIOT |
Adjoint |
Iradj SOBHANI |
Axe(s) de recherche
|
Le laboratoire axe ses recherches sur le rôle du microbiome intestinal ainsi que des changements épigénétiques dans l'intestin afin :
|